Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Basal Histamine H 4 Receptor Activation: Agonist Mimicry by the Diphenylalanine Motif.

Tytuł:
Basal Histamine H 4 Receptor Activation: Agonist Mimicry by the Diphenylalanine Motif.
Autorzy:
Wifling D; Department of Pharmaceutical/Medicinal Chemistry II, Institute of Pharmacy, University of Regensburg, Universitätsstr. 31, 93053, Regensburg, Germany.
Pfleger C; Institute for Pharmaceutical and Medicinal Chemistry, Heinrich Heine University Düsseldorf, Universitätsstr. 1, 40225, Düsseldorf, Germany.
Kaindl J; Computer Chemistry Center, Department of Chemistry and Pharmacy, University of Erlangen-Nürnberg, Nägelsbachstr. 25, 91052, Erlangen, Germany.
Ibrahim P; Computer Chemistry Center, Department of Chemistry and Pharmacy, University of Erlangen-Nürnberg, Nägelsbachstr. 25, 91052, Erlangen, Germany.
Kling RC; Computer Chemistry Center, Department of Chemistry and Pharmacy, University of Erlangen-Nürnberg, Nägelsbachstr. 25, 91052, Erlangen, Germany.
Buschauer A; Department of Pharmaceutical/Medicinal Chemistry II, Institute of Pharmacy, University of Regensburg, Universitätsstr. 31, 93053, Regensburg, Germany.
Gohlke H; Institute for Pharmaceutical and Medicinal Chemistry, Heinrich Heine University Düsseldorf, Universitätsstr. 1, 40225, Düsseldorf, Germany.; John von Neumann Institute for Computing (NIC), Jülich Supercomputing Centre (JSC) &, Institute for Complex Systems-Structural Biochemistry (ICS 6), Forschungszentrum Jülich GmbH, Wilhelm-Johnen-Str., 52425, Jülich, Germany.
Clark T; Computer Chemistry Center, Department of Chemistry and Pharmacy, University of Erlangen-Nürnberg, Nägelsbachstr. 25, 91052, Erlangen, Germany.
Źródło:
Chemistry (Weinheim an der Bergstrasse, Germany) [Chemistry] 2019 Nov 18; Vol. 25 (64), pp. 14613-14624. Date of Electronic Publication: 2019 Oct 16.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: Weinheim, Germany : Wiley-VCH
MeSH Terms:
Phenylalanine/*analogs & derivatives
Receptors, Histamine H4/*agonists
Animals ; Binding Sites ; Catalytic Domain ; Dipeptides ; Humans ; Mice ; Molecular Dynamics Simulation ; Mutagenesis, Site-Directed ; Phenylalanine/chemistry ; Protein Stability ; Receptors, Histamine H4/genetics ; Receptors, Histamine H4/metabolism
References:
J Am Chem Soc. 2010 Aug 25;132(33):11443-5. (PMID: 20669948)
Trends Pharmacol Sci. 2011 Jan;32(1):35-42. (PMID: 21075459)
J Mol Biol. 2011 Dec 9;414(4):611-23. (PMID: 22037586)
Nature. 2013 Dec 5;504(7478):101-6. (PMID: 24256733)
Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18684-9. (PMID: 22031696)
Nature. 2009 May 21;459(7245):356-63. (PMID: 19458711)
Annu Rev Pharmacol Toxicol. 2013;53:531-56. (PMID: 23140243)
Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4689-94. (PMID: 19258456)
J Comput Chem. 2005 Dec;26(16):1701-18. (PMID: 16211538)
Nature. 2011 Jun 22;475(7354):65-70. (PMID: 21697825)
J Chem Theory Comput. 2008 Mar;4(3):435-47. (PMID: 26620784)
J Comput Chem. 2004 Jul 15;25(9):1157-74. (PMID: 15116359)
Cell. 2013 Jan 31;152(3):532-42. (PMID: 23374348)
J Comput Chem. 2004 Oct;25(13):1605-12. (PMID: 15264254)
Nature. 2017 Jul 6;547(7661):68-73. (PMID: 28607487)
Mol Pharmacol. 2002 Jul;62(1):38-47. (PMID: 12065753)
Proteins. 2001 Aug 1;44(2):150-65. (PMID: 11391777)
Chem Rev. 2017 Jan 11;117(1):139-155. (PMID: 27622975)
PLoS One. 2015 Jan 28;10(1):e0117185. (PMID: 25629160)
J Med Chem. 2019 Jun 13;62(11):5358-5369. (PMID: 31074983)
Trends Pharmacol Sci. 2013 Jan;34(1):67-84. (PMID: 23245528)
J Pharmacol Exp Ther. 2008 Oct;327(1):88-96. (PMID: 18635748)
Nature. 2013 Feb 14;494(7436):185-94. (PMID: 23407534)
Nature. 2011 Jul 19;477(7366):549-55. (PMID: 21772288)
J Chem Phys. 2008 Mar 28;128(12):125103. (PMID: 18376978)
Nat Chem. 2014 Jan;6(1):15-21. (PMID: 24345941)
Science. 2000 Aug 4;289(5480):739-45. (PMID: 10926528)
J Chem Inf Model. 2013 Apr 22;53(4):1007-15. (PMID: 23517329)
J Biol Chem. 1988 Jul 25;263(21):10267-71. (PMID: 2899076)
Science. 2007 Nov 23;318(5854):1258-65. (PMID: 17962520)
Nature. 2011 Jan 13;469(7329):241-4. (PMID: 21228877)
J Biol Chem. 1994 Nov 25;269(47):29557-64. (PMID: 7961941)
Br J Pharmacol. 2009 May;157(1):24-33. (PMID: 19309354)
Nature. 2011 Jan 13;469(7329):175-80. (PMID: 21228869)
Naunyn Schmiedebergs Arch Pharmacol. 2002 Nov;366(5):381-416. (PMID: 12382069)
Curr Med Chem. 2012;19(8):1090-109. (PMID: 22300046)
Chemistry. 2019 Nov 18;25(64):14613-14624. (PMID: 31498478)
Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3540-5. (PMID: 11891336)
PLoS One. 2015 Jul 06;10(7):e0130289. (PMID: 26147762)
Nature. 2016 Mar 17;531(7594):335-40. (PMID: 26958838)
Methods Enzymol. 2013;522:21-35. (PMID: 23374178)
J Comput Chem. 2010 Aug;31(11):2169-74. (PMID: 20336801)
Trends Pharmacol Sci. 1993 Aug;14(8):303-7. (PMID: 8249148)
J Chem Theory Comput. 2017 Dec 12;13(12):6343-6357. (PMID: 29112408)
Proteins. 2006 Nov 15;65(3):712-25. (PMID: 16981200)
Naunyn Schmiedebergs Arch Pharmacol. 2011 May;383(5):457-70. (PMID: 21359967)
Trends Biochem Sci. 2014 May;39(5):233-44. (PMID: 24767681)
Trends Pharmacol Sci. 2015 Jan;36(1):22-31. (PMID: 25541108)
Nature. 2012 Dec 20;492(7429):387-92. (PMID: 23222541)
Br J Pharmacol. 2012 Mar;165(6):1688-1703. (PMID: 21864311)
Biochim Biophys Acta. 2007 Apr;1768(4):794-807. (PMID: 17188232)
FASEB J. 2001 Mar;15(3):598-611. (PMID: 11259378)
Br J Pharmacol. 2015 Feb;172(3):785-98. (PMID: 24903527)
Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):10982-7. (PMID: 23781107)
Proc Natl Acad Sci U S A. 2015 Nov 17;112(46):14254-9. (PMID: 26578769)
Nature. 2012 Jan 25;482(7386):547-51. (PMID: 22278061)
J Chem Inf Model. 2008 Jul;48(7):1455-63. (PMID: 18553960)
Beilstein J Org Chem. 2017 Jun 2;13:1071-1078. (PMID: 28684986)
PLoS One. 2013 Jun 24;8(6):e67244. (PMID: 23826246)
Protein Sci. 1997 Mar;6(3):676-88. (PMID: 9070450)
Nat Commun. 2017 Nov 8;8(1):1365. (PMID: 29118336)
Proteins. 2011 Apr;79(4):1089-108. (PMID: 21246632)
J Biol Chem. 2001 Aug 3;276(31):29171-7. (PMID: 11375997)
J Mol Graph Model. 2002 Dec;21(3):195-207. (PMID: 12463638)
J Pharmacol Exp Ther. 2010 May;333(2):382-92. (PMID: 20106995)
Protein Sci. 1997 Jun;6(6):1333-7. (PMID: 9194194)
Grant Information:
GRK 1910 Deutsche Forschungsgemeinschaft; FOR 2518 (project P7, GO 1367/2-1) Deutsche Forschungsgemeinschaft
Contributed Indexing:
Keywords: GPCR; basal activation; computational chemistry; molecular dynamics; rigidity analysis
Substance Nomenclature:
0 (Dipeptides)
0 (Receptors, Histamine H4)
2577-40-4 (phenylalanylphenylalanine)
47E5O17Y3R (Phenylalanine)
Entry Date(s):
Date Created: 20190910 Date Completed: 20191120 Latest Revision: 20231104
Update Code:
20240105
PubMed Central ID:
PMC7687114
DOI:
10.1002/chem.201902801
PMID:
31498478
Czasopismo naukowe
Histamine H 4 receptor (H 4 R) orthologues are G-protein-coupled receptors (GPCRs) that exhibit species-dependent basal activity. In contrast to the basally inactive mouse H 4 R (mH 4 R), human H 4 R (hH 4 R) shows a high degree of basal activity. We have performed long-timescale molecular dynamics simulations and rigidity analyses on wild-type hH 4 R, the experimentally characterized hH 4 R variants S179M, F169V, F169V+S179M, F168A, and on mH 4 R to investigate the molecular nature of the differential basal activity. H 4 R variant-dependent differences between essential motifs of GPCR activation and structural stabilities correlate with experimentally determined basal activities and provide a molecular explanation for the differences in basal activation. Strikingly, during the MD simulations, F169 45.55 dips into the orthosteric binding pocket only in the case of hH 4 R, thus adopting the role of an agonist and contributing to the stabilization of the active state. The results shed new light on the molecular mechanism of basal H 4 R activation that are of importance for other GPCRs.
(© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.)
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies